RSV Vaccine for Adults: Studies, Uses, and Patient Conversations - Frankly Speaking Ep 346

<p>Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-346'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-346</a></p> <p>Overview: As we encounter more patients asking about the recent FDA approval of a new respiratory syncytial virus (RSV) vaccine for older adults, it’s crucial that we keep up to date. Join us as we review the supporting studies, indications, and precautions, giving you confidence in conversations with inquiring patients. </p> <p>Episode resource links:</p> <ul><li><a href='https://www.fda.gov/news-events/press-announcements/fda-approves-first-respiratory-syncytial-virus-rsv-vaccine'>https://www.fda.gov/news-events/press-announcements/fda-approves-first-respiratory-syncytial-virus-rsv-vaccine</a></li> </ul> <p>Guest: Robert A. Baldor MD, FAAFP   Music Credit: Richard Onorato</p>